Incannex Healthcare (IXHL) Shares Outstanding (Weighted Average) (2020 - 2026)
Incannex Healthcare's (IXHL) quarterly Shares Outstanding (Weighted Average) came in at $12.3 million in Q1 2026, up 1786.94% year-on-year from $654418.0 in Q1 2025, and down 96.47% quarter-over-quarter from $349.5 million in Q4 2025.
Incannex Healthcare (IXHL) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Shares Outstanding (Weighted Average) across 7 years of filings, most recently posting $12.3 million for Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $12.3 million, up 1786.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.3 million (up 1786.94% YoY), and the FY2025 annual result was $34.5 million, up 113.15% from the prior year.
- Shares Outstanding (Weighted Average) came in at $12.3 million for Q1 2026 at Incannex Healthcare, down from $349.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.2 billion in Q2 2022 to a low of $654418.0 in Q1 2025.
- The 5-year median for Shares Outstanding (Weighted Average) is $15.9 million (2023), against an average of $136.2 million.
- Across the five-year window, Shares Outstanding (Weighted Average) surged 11811.54% in 2022 and slumped 98.71% in 2023, its largest moves.
- Incannex Healthcare's Shares Outstanding (Weighted Average) stood at $14.9 million in 2022, then advanced by 6.52% to $15.9 million in 2023, then climbed by 10.65% to $17.6 million in 2024, then soared by 1889.75% to $349.5 million in 2025, then slumped by 96.47% to $12.3 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $12.3 million (Q1 2026), $349.5 million (Q4 2025), and $310.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 100.50 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 5.11 Bn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 88.01 Mn |
| 10 | Incannex Healthcare | 47.42 Mn | 47.42 Mn | - | 12.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.35 Mn |
| Dec 31, 2025 | 349.46 Mn |
| Sep 30, 2025 | 310.31 Mn |
| Jun 30, 2025 | 34.45 Mn |
| Mar 31, 2025 | 654,418.00 |
| Dec 31, 2024 | 17.56 Mn |
| Sep 30, 2024 | 17.64 Mn |
| Jun 30, 2024 | 16.16 Mn |
| Mar 31, 2024 | 15.87 Mn |
| Dec 31, 2023 | 15.87 Mn |
| Sep 30, 2023 | 15.87 Mn |
| Jun 30, 2023 | 15.38 Mn |
| Mar 31, 2023 | 15.22 Mn |
| Dec 31, 2022 | 14.90 Mn |
| Jun 30, 2022 | 1.19 Bn |
| Jun 30, 2021 | 10.00 Mn |
| Jun 30, 2020 | 5.75 Mn |